#Spain #Madrid #Biopharma #Astellas #Veeva Summit

Biopharmaceutical Pioneers Gather to Shape the Future of Life Sciences

The Veeva Commercial Summit Europe, held on November 5-6 in Madrid, Spain, promises to be a landmark event in the world of biopharmaceuticals. With representatives from major companies like Astellas, Bayer AG, Boehringer Ingelheim, LEO Pharma, Moderna, and MSD, this summit is set to explore cutting-edge innovations in the industry.

The event is a vital platform for industry experts to exchange insights and foster discussions aimed at enhancing performance and efficiency within the sector. Participants will learn about the latest advancements in the Veeva Commercial Cloud, including the next-gen Vault CRM Suite and Veeva Data Cloud. A key highlight will be the demonstration of Veeva AI Agents for Vault CRM, which includes several features like the Pre-call Agent and Voice Agent, designed to elevate productivity in the field and improve customer engagement.

Key Sessions to Look Forward To

More than 100 sessions have been scheduled during the two-day summit, targeting the future direction of biopharma strategies. Some significant topics include:

• - Integrating Sales, Marketing, and Medical Technology: Bayer AG and Otsuka Europe will discuss how unified customer views enable better connections and improve engagement.
• - Understanding Healthcare Representative Preferences: LEO Pharma will share insights on using data to bridge gaps between expectations and experiences in customer interactions.
• - Enhancing Go-to-Market Strategies: Bayer AG will present how it is evolving its market strategies with its next-gen CRM Suite to achieve a more customer-centric approach.

Deepening Customer Insights

MSD will elaborate on how extensive KOL (Key Opinion Leader) data and adaptable workflows enhance KOL engagement, while Bayer will explain how it is strengthening its global dataset to leverage AI and optimize economic outcomes.

Accelerating Content Lifecycle for Effective Engagement

Astellas will demonstrate the transition from fragmented planning and execution to cohesive content strategies backed by integrated technologies.

Chris Moore, President of Veeva Europe, stated, "The Veeva Summit is where executives come together to explore innovative ideas and agent-based AI technologies that can expedite the delivery of medications to the right patients. Insights and best practices shared here will enhance collective knowledge and advance progress across the industry."

The Veeva Commercial Summit stands as one of the largest gatherings of biopharmaceutical leaders in Europe, bringing together over 1,200 industry professionals. The summit is exclusive to those within the life sciences sector. Registration details and the full agenda can be found at veeva.com/eu/Summit.

About Veeva Systems

Veeva delivers the industry's cloud for life sciences, providing software, data, and consulting services with a focus on innovation, product excellence, and customer success. The company serves over 1,500 customers, ranging from the largest biopharma firms to emerging biotech companies. As a Public Benefit Corporation, Veeva is committed to aligning the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves.

For more information, visit veeva.com/eu.

Please note that this press release contains forward-looking statements regarding Veeva’s products and services, along with anticipated results from their use. Actual outcomes may differ significantly from those expressed, and Veeva undertakes no obligation to update such statements.